107492-32-0

Basic information

• Product Name: Hexanoic acid, 2-hydroxy-6-[[(phenylmethoxy)carbonyl]amino]-, methyl ester, (2S)-
• CAS NO: 107492-32-0
• Molecular Formula: C15H21NO5
• Molecular Weight: 295.335
• Mol File: 107492-32-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Hexanoic acid, 2-hydroxy-6-[[(phenylmethoxy)carbonyl]amino]-, methyl ester, (2S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Hexanoic acid, 2-hydroxy-6-[[(phenylmethoxy)carbonyl]amino]-, methyl ester, (2S)-(107492-32-0)
• EPA Substance Registry System: Hexanoic acid, 2-hydroxy-6-[[(phenylmethoxy)carbonyl]amino]-, methyl ester, (2S)-(107492-32-0)

Safety Data

• Hazardous Substances Data: 107492-32-0(Hazardous Substances Data)

Upstream product

• 186581-53-3 diazomethane 
• 59221-35-1 (S)-6-[[(Phenylmethoxy)carbonyl]amino]-2-hydroxyhexanoic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 126110-77-8 ({(S)-6-Benzyloxycarbonylamino-2-[hydroxy-(4-phenyl-butyl)-phosphinoyloxy]-hexanoyl}-indan-2-yl-amino)-acetic acid benzyl ester 
• 126110-76-7 (S)-oxy>-1-oxo-6-<<(phenylmethoxy)carbonyl>amino>hexyl>amino>acetic acid phenylmethyl ester 
• 126110-46-1 ({(S)-6-Amino-2-[hydroxy-(4-phenyl-butyl)-phosphinoyloxy]-hexanoyl}-indan-2-yl-amino)-acetic acid 
• 107492-21-7 (S)-N-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-N-cyclohexylglycine 
• 107492-15-9 (S)-6-Benzyloxycarbonylamino-2-[hydroxy-(4-phenyl-butyl)-phosphinoyloxy]-hexanoic acid methyl ester 
• 107492-16-0 (S)-2-<oxy>-6-<<(phenylmethoxy)carbonyl>amino>hexanoic acid 
• 126187-84-6 {4-[(S)-2,5-Dioxo-2-(4-phenyl-butyl)-2λ⁵-[1,3,2]dioxaphospholan-4-yl]-butyl}-carbamic acid benzyl ester 
• 107492-14-8 (S)-6-Benzyloxycarbonylamino-2-(4-phenyl-butylphosphinoyloxy)-hexanoic acid methyl ester 

Relevant articles and documents

POLYBIOTIN COMPOUNDS FOR MAGNETIC RESONANCE IMAGINING AND DRUG DELIVERY

The invention relates generally to biotin-containing compounds that are useful as imaging agents and drug-delivery agents. Another aspect of the invention relates to the aforementioned compounds chelated to a metal atom. In a preferred embodiment, the metal atom is a gadolinium. Another aspect of the invention relates to a compound comprising three biotin moieties and a pharmaceutical agent covalently bound to a heterocyclic core. In certain embodiments, the pharmaceutical agent is an antibiotic, antiviral, or radionuclide. Another aspect of the present invention relates to a method of treating disease involving administering the compounds of the invention to a mammal. Another aspect of the present invention relates to a method of acquiring a magnetic resonance image using the compounds of the invention.

Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors

-